| 摘要 |
<p>The present invention relates to the field of transdermal delivery of pharmaceutical compositions, which have acceptable in vitro performance and good bioavailability. In particular the transdermal pharmaceutical compositions of the present invention in liquid and gel formulations, for example, Fluoxetine (FLX) HCI and Olanzapine (OLZ) in a transdermal patch dosage form, alone and in combination with each other. In addition, describes a new lipophilic penetration enhancer (Olanzapine), which helps the hydrophilic molecules (Fluoxetine HCI) to penetrate though the skin more efficiently than alone.</p> |
